Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
RLVT-903 by Releviate Therapeutics for Peripheral Neuropathy (Sensory Neuropathy): Likelihood of Approval
RLVT-903 is under clinical development by Releviate Therapeutics and currently in Phase I for Peripheral Neuropathy (Sensory Neuropathy). According to...